On November 16th, 2021, the Board of Directors of Cannabics Pharmaceuticals Inc. increased the size of the Board to five members, and appointed Mr. Shaul Yemal to the Board as an Independent Director and as a member of the Audit Committee. Mr. Yemal, 75, brings decades of transnational management and finance experience. Previously Mr. Yemal served as Senior Economist in the Division of Economic Consulting for the Ministry of Finance, Budget Division of the Minister of Finance and Manager of the Economic and Planning Division of the Ministry of Energy (Israel). Mr. Yemal was acting Chair of Financial, Auditor and Compensation Committees for numerous companies both public and private.